Study guide

9.1 Cell Injury, Adaptation, Necrosis, Apoptosis, Accumulations & Calcification

Philippine Physician Licensure Examination Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: PLE Structure, Eligibility & Study Strategy

1.1 PLE Format, 2026 Schedule & the Statutory Passing Rule 1.2 Eligibility, Internship, PRC Filing & Test-Day Rules 1.3 Reading the 2025 Tables of Specifications & Building a Study Plan

2 Chapter 2: Physiology I: Cells, Blood, Nerve & Muscle

2.1 Homeostasis, Cell Function, Membrane Transport & Resting Potential 2.2 Blood Cells, Immunity, Hemostasis, Fibrinolysis & Blood Distribution 2.3 Action Potentials, Conduction, the Neuromuscular Junction & Muscle Contraction

3 Chapter 3: Physiology II: Cardiovascular & Respiratory Systems

3.1 Cardiac Electrophysiology, the Cardiac Cycle & the Heart as a Pump 3.2 Circulation: Resistance, Venous Return, Coronary Flow, Microcirculation & Fetal Circulation 3.3 Respiratory Mechanics, Gas Exchange, Gas Transport, Control of Breathing & Extreme Environments

4 Chapter 4: Physiology III: Gastrointestinal, Endocrine, Renal & Reproductive Systems

4.1 Gastrointestinal Physiology: Secretion, Motility, Digestion & Absorption 4.2 Endocrine Physiology: Hormone Chemistry, Axes, Calcium & Fuel Regulation 4.3 Renal Physiology, Body Fluid Balance & Acid-Base Regulation 4.4 Reproductive Physiology: Sexual Differentiation, Spermatogenesis, the Menstrual Cycle, Parturition & Lactation

5 Chapter 5: Physiology IV: Neurophysiology & Special Senses

5.1 Sensory Receptors, Somatic Sensation, Spinal Reflexes & Motor Control 5.2 Higher Brain Functions, Sleep, the Autonomic Nervous System, Cerebral Blood Flow & the Special Senses

6 Chapter 6: Legal Medicine I: Medicolegal Examination, Identification & Death

6.1 The Medicolegal Examination, Physical Evidence & the Crime Scene 6.2 Identification of the Living, the Dead & Skeletal Remains 6.3 Thanatology: Death, Brain Death, Postmortem Changes & Time of Death

7 Chapter 7: Legal Medicine II: Injuries, Sexual Crimes, Reproduction, Mental State & Poisoning

7.1 Physical Injuries: Revised Penal Code Classes, Wounds, Gunshot Injuries, Asphyxia & Burns 7.2 Sexual Crimes, Violence Against Women & Child Abuse 7.3 Medicolegal Aspects of Pregnancy, Delivery, Abortion, Infanticide, Paternity & Marriage 7.4 Disturbance of Mentality: Insanity, Intoxication, Capacity & the Mental Health Act 7.5 Forensic Toxicology & Poisoning: Diagnosis, Evidence, Antidotes & Philippine Laws

8 Chapter 8: Legal Medicine III: Reports, Regulation, Liability & Ethics

8.1 The Medicolegal Report, the Death Certificate, Autopsy Rules & Communicating with Relatives 8.2 Licensure & Regulation of Medical Practice: RA 2382, the Board of Medicine, PRC & Prescribing Laws 8.3 Medical Malpractice: Civil, Criminal & Administrative Liability and Key Philippine Doctrines 8.4 Physician Relationships Under the PMA Code of Ethics: Patients, Colleagues, Allied Health, Students, Industry, HMOs, Hospitals & PhilHealth 8.5 Bioethical Principles, Informed Consent, Confidentiality, End-of-Life & Research Ethics

9 Chapter 9: Pathology I: Cell Injury, Inflammation & Hemodynamics

9.1 Cell Injury, Adaptation, Necrosis, Apoptosis, Accumulations & Calcification 9.2 Acute & Chronic Inflammation, Granulomas, Systemic Effects & Tissue Repair 9.3 Hemodynamic Disorders: Edema, Hemorrhage, Thrombosis, Embolism, Infarction, DIC & Shock

10 Chapter 10: Pathology II: Genetics, Neoplasia, Immunity, Environment & Infection

10.1 Genetic Disorders & Neoplasia: Mendelian, Chromosomal, Non-Classic Inheritance, Tumor Biology & Markers 10.2 Immunopathology: Hypersensitivity, Autoimmunity, Immunodeficiency & Transplant Rejection 10.3 Environmental & Nutritional Pathology: Air Pollution, Tobacco, Metals, Occupational Lung Disease & Deficiency States 10.4 Pathology of Infectious Diseases: Transmission, Tissue Reaction Patterns & Diagnostic Morphology

11 Chapter 11: Pathology III: Gastrointestinal, Cardiovascular & Respiratory Pathology

11.1 Gastrointestinal, Hepatic, Biliary & Pancreatic Pathology 11.2 Cardiovascular & Collagen Pathology: Heart Failure, Congenital, Ischemic, Hypertensive, Valvular, Pericardial & Myocardial Disease 11.3 Respiratory Pathology: Atelectasis, Edema, ARDS, Obstructive & Restrictive Disease, Vascular Disease, Infections, Tumors & Pleura

12 Chapter 12: Pathology IV: Hematopoietic, Genitourinary, Endocrine & Nervous System Pathology

12.1 Hematopoietic Pathology: Anemias, Polycythemia, Bleeding Disorders, DIC & Lymphoid and Myeloid Neoplasms 12.2 Genitourinary Pathology: Glomerular, Tubulointerstitial, Vascular & Cystic Kidney Disease, Renal Tumors, Obstruction & Genital Disorders 12.3 Endocrine Pathology: Pancreas, Adrenal, Parathyroid, Thyroid & Pituitary Disorders 12.4 Nervous System Pathology: Cerebrovascular Disease, Edema & Herniation, Infections, Degenerative & Demyelinating Disease, Tumors

13 Chapter 13: Biochemistry I: Carbohydrate, Protein, Genetic & Energy Biochemistry

13.1 Carbohydrate Chemistry, Digestion, Glycolysis, Pyruvate Dehydrogenase & the Pentose Phosphate Pathway 13.2 Gluconeogenesis, Glycogen, Lipogenesis, Ketogenesis & Hormonal Control of Fuel Metabolism 13.3 Protein Digestion, Amino Acid Catabolism, the Urea Cycle, Heme Synthesis, Porphyrias & Bilirubin Metabolism 13.4 Amino Acids & Proteins: Structure, Properties, Separation, Specialized Products, Collagen & Protein Misfolding in Alzheimer Disease 13.5 Molecular Genetics & Enzymes: Replication, Repair, Gene Expression, Molecular Techniques, Lysosomal Storage Diseases & Enzyme Kinetics 13.6 Bioenergetics, the Citric Acid Cycle, Oxidative Phosphorylation, Muscle Energetics & Nucleotide Metabolism

14 Chapter 14: Biochemistry II: Respiratory, Nutritional, Immunologic & Cardiovascular Biochemistry

14.1 Respiratory Biochemistry: Hemoglobin, Oxygen Binding, Hemoglobinopathies, Thalassemias, Methemoglobin, Buffers & Acid-Base Balance 14.2 Nutrition Biochemistry: Dietary Standards (RENI to PDRI 2015), Food Guides, Protein Quality, Energy Expenditure, Breast Milk, Vitamins, Minerals & Blood Components 14.3 Immunology: Innate & Adaptive Immunity, the Immune Response, Antibodies, Complement, Cytokines & MHC 14.4 Cardiovascular Biochemistry: Cholesterol, Lipoproteins, Dyslipidemias, Atherogenesis, Myocardial Energetics, Biomarkers & Heart Failure

15 Chapter 15: Anatomy I: Thorax, Abdomen, Pelvis & Back

15.1 Thorax: Thoracic Wall, Breast, Pleura & Lungs, Mediastinum, Heart & Great Vessels 15.2 Abdomen: Abdominal Wall & Inguinal Region, Peritoneum, Viscera, Diaphragm & Posterior Abdominal Wall 15.3 Pelvis & Perineum: Bony Pelvis, Pelvic Floor, Pelvic Viscera, Vessels & Nerves, Perineal Pouches & the Anal Canal 15.4 Back & Spinal Column: Vertebrae, Curvatures, Joints, Back Muscles, Spinal Cord, Meninges & Cord Syndromes

16 Chapter 16: Anatomy II: Upper Limb, Lower Limb & Skin

16.1 Upper Limb: Bones, Superficial Veins, Shoulder Muscles, Axilla & Brachial Plexus, Arm, Cubital Fossa, Forearm, Hand & Joints 16.2 Lower Limb: Bones, Venous & Lymphatic Drainage, Thigh, Gluteal Region, Popliteal Fossa, Leg Compartments, Foot, Joints & Gait 16.3 Skin & Appendages: Epidermis, Junctions, Dermis, Subcutaneous Tissue, Fascia, Nerves, Vessels, Lymphatics, Hair, Nails & Glands

17 Chapter 17: Anatomy III: Head, Neck & Histology

17.1 Head I: Skull & Cranial Foramina, Scalp, Face & Parotid, Orbit, Temporal & Infratemporal Fossae, TMJ, Oral Region, Nose & Ear 17.2 Head II: Meninges & Dural Venous Sinuses, Brain Regions & Ventricles, Blood Supply, Cranial Nerves, Pituitary & Pineal, Brainstem Syndromes 17.3 Neck: Cervical Vertebrae & Hyoid, Fascial Layers, Superficial Muscles, Triangles, Root of the Neck, Visceral Layers & Lymphatics 17.4 Histology: Cells, Epithelium & Glands, Connective Tissue & Fat, Cartilage & Bone, Blood & Hematopoiesis, Muscle, Nerve, Vessels, Lymphoid Organs & Organ Histology

18 Chapter 18: Microbiology I: Foundations, Respiratory & Cardiovascular Infections

18.1 Microbiology Foundations: The Organ-System TOS, Specimens & Stains, Gram-Positive and Gram-Negative Bacteria 18.2 Respiratory Infections: Tonsillitis, Sinusitis & Mastoiditis, Bronchitis, Community-Acquired & Severe Pneumonia, Bronchiectasis and Paragonimiasis 18.3 Tuberculosis, Leprosy & Nontuberculous Mycobacteria: Pathogenesis, Diagnosis, NTP Regimens & Prevention 18.4 Cardiovascular Infections: Infective Endocarditis, Rheumatic Fever & Rheumatic Heart Disease, Myocarditis, Pericarditis and Septic Thrombophlebitis

19 Chapter 19: Microbiology II: Gastrointestinal & Nervous System Infections

19.1 Gastrointestinal Infections I: Gastroenteritis & Enterocolitis, Cholera, Typhoid & Salmonellosis, Shigellosis, Food Poisoning and Viral Hepatitis 19.2 Gastrointestinal Infections II: Amebiasis, Giardiasis & Cryptosporidiosis, Soil-Transmitted Helminths, Pinworm, Capillariasis and Tapeworms 19.3 Nervous System Infections: Meningitis & CSF Patterns, Encephalitis, Rabies and DOH PEP, Spinal Cord Infections, Tetanus & Botulism, Paralytic Shellfish Poisoning

20 Chapter 20: Microbiology III: Genitourinary, Reproductive, Blood & Skin Infections

20.1 Genitourinary Infections: Cystitis & Pyelonephritis, Urine Diagnostics, Urethritis, Balanoposthitis, Pelvic Inflammatory Disease and Genital Ulcers 20.2 Reproductive Tract Infections & STIs: Syphilis, Genital & Neonatal Herpes, HPV, Molluscum, CMV, Trichomoniasis & Vaginitis, Cervicitis, Prostatitis and Orchitis 20.3 Hematopoietic & Lymphatic Infections: Dengue and Other Hemorrhagic Fevers, Malaria, Lymphatic Filariasis, Lymphogranuloma Venereum and Epstein-Barr Virus 20.4 Integumentary Infections: Viral Exanthems (Measles, Mumps, Rubella, Varicella, Smallpox & Mpox, Fifth Disease), Herpesviruses, Fungal Skin Infections and Tick-Borne Diseases

21 Chapter 21: Microbiology IV: Musculoskeletal & Multisystemic Infections

21.1 Musculoskeletal & Soft-Tissue Infections: Osteomyelitis, Septic & Reactive Arthritis, Pyomyositis & Gas Gangrene, Cellulitis, Necrotizing Fasciitis and Bite Wounds 21.2 Multisystemic Infections I: Septicemia, Septicopyemia & Septic Shock, Leptospirosis and Schistosomiasis japonica 21.3 Multisystemic Infections II: HIV/AIDS Virology, the Philippine Epidemic & RA 11166, Diagnosis (rHIVda), ART, Prevention and Opportunistic Infections including Toxoplasmosis

22 Chapter 22: Obstetrics I: Prenatal Care, Labor & Obstetric Bleeding

22.1 Prenatal Care: Diagnosis of Pregnancy, Maternal Physiology, Dating, Nutrition & Supplements, Screening Tests and the DOH Antenatal Package 22.2 Labor & Parturition: Signs of Labor, Pelvis and Passenger, Stages and Cardinal Movements, Partograph, Fetal Monitoring, Dystocia, Shoulder Dystocia, Operative Delivery, Preterm Labor, PROM and Adolescent Pregnancy 22.3 Early Pregnancy Risks & Bleeding: Hyperemesis, Spontaneous Abortion, Recurrent Loss & Cervical Insufficiency, Ectopic Pregnancy, Hydatidiform Mole & Gestational Trophoblastic Neoplasia 22.4 Hemorrhagic Complications of Pregnancy: Placenta Previa, Abruption, Vasa Previa, Placenta Accreta Spectrum, Uterine Rupture, Third-Stage Management and Postpartum Hemorrhage

23 Chapter 23: Obstetrics II: Fetal, Hypertensive, Medical, Infectious & Postpartum Problems

23.1 Fetal Complications: Malpresentation & Breech, Macrosomia, Fetal Growth Restriction, Amniotic Fluid Disorders, Antepartum Surveillance, Rh Alloimmunization, Multiple Gestation and Post-Term Pregnancy 23.2 Hypertension & Diabetes in Pregnancy: Classification, Preeclampsia Pathogenesis and Prevention, Severe Features, Eclampsia & HELLP, Magnesium Sulfate, Gestational and Pregestational Diabetes 23.3 Medical & Surgical Disorders in Pregnancy: Drug Pharmacokinetics, Epilepsy, Thyroid, Heart Disease, SLE & APS, Asthma, Liver Disorders, Anemia, Dermatoses, Appendicitis, Gallstones, Stones and Trauma 23.4 Perinatal Infections: Triple Elimination (HIV, Syphilis, Hepatitis B), Group B Streptococcus, Chorioamnionitis, Gonorrhea & Chlamydia, Condyloma, Herpes and the TORCH Infections 23.5 Postpartum Care & Complications: Normal Puerperium, Postnatal Visits, Breastfeeding, Puerperal Fever and Infection, Mastitis, Late Hemorrhage, Mood Disorders, VTE and Postpartum Contraception

24 Chapter 24: Gynecology I: Benign Disorders, Infections & Contraception

24.1 Benign Lower Genital Tract Disorders & Pelvic Floor: Vulvar Dermatoses, Bartholin Cysts, Vaginal and Cervical Lesions, Premalignant Lesions, Pelvic Organ Prolapse, Urinary Incontinence and Fistula 24.2 Benign Upper Genital Tract Disorders: Leiomyoma, Adenomyosis & Endometriosis, Endometrial Polyps and Hyperplasia, Functional Cysts and Benign Ovarian Tumors, Adnexal Torsion and Tubal Disease 24.3 Infections of the Female Reproductive Tract: Burden & Screening, Syndromic Management, Vaginitis and Cervicitis, Pelvic Inflammatory Disease & Tubo-Ovarian Abscess, Genital Tuberculosis and Toxic Shock 24.4 Contraception & Family Planning: The RH Law, Effectiveness, Natural and Barrier Methods, Hormonal Methods, IUDs, Permanent Methods, Emergency Contraception and the WHO Eligibility Criteria

25 Chapter 25: Gynecology II: Reproductive Endocrinology, Oncology & Special Issues

25.1 Reproductive Endocrinology & Menstrual Disorders: The Menstrual Cycle, Puberty, Abnormal Uterine Bleeding (PALM-COEIN), Amenorrhea, PCOS, Hyperprolactinemia, Dysmenorrhea, Infertility, Menopause, HRT and Osteoporosis 25.2 Gynecologic Oncology: Cervical Cancer Screening, Staging & Treatment, Endometrial Cancer and Lynch Syndrome, Ovarian Tumors and BRCA, Vulvar and Vaginal Cancer, Survival and Quality of Life 25.3 Contemporary Issues & Pediatric and Adolescent Gynecology: Violence Against Women, Sexual Assault Care, Breast Disorders, Ethics of Maternal-Fetal Conflict, and Gynecologic Problems of Children and Adolescents

26 Chapter 26: Pediatrics I: Newborn, Growth, Nutrition, Immunization & Infections

26.1 The Newborn: Normal Findings and Variants, EINC (Unang Yakap), APGAR, Neonatal Resuscitation, Routine Care & Newborn Screening, Jaundice, Respiratory Distress, Hypoglycemia and Neonatal Sepsis 26.2 Growth, Development & Nutrition: Growth Parameters, Milestones and Red Flags, Speech Delay, Autism, ADHD & Global Delay, Breastfeeding and Feeding, Micronutrient Deficiencies, Malnutrition and Obesity 26.3 Immunization: RA 10152 and the National Immunization Program Schedule, Fully Immunized Child, School-Based Immunization, Other Recommended Vaccines, Vaccine Types, Cold Chain, Contraindications and AEFI 26.4 Pediatric Infectious Diseases: Bacterial (Diphtheria to Congenital Syphilis), Childhood TB, Viral Exanthems and Infections, Dengue in Children, Pediatric HIV, Protozoal, Helminthic and Fungal Infections

27 Chapter 27: Pediatrics II: Respiratory, Cardiovascular, Neurologic & Gastrointestinal Disorders

27.1 Pediatric Respiratory Disorders: IMCI Danger Signs and Cough Assessment, URI, Tonsillitis & Peritonsillar Abscess, Croup, Epiglottitis, Foreign Body, Bronchiolitis, Pneumonia, Pleural Effusion and Complications 27.2 Pediatric Cardiovascular & Collagen Disorders: Heart Sounds and Murmurs, Acyanotic and Cyanotic Congenital Heart Disease, Eisenmenger, Hypercyanotic Spells, Heart Failure, Rheumatic Fever, Hypertension, Endocarditis, Kawasaki, SLE, JIA, Dermatomyositis and Pediatric Resuscitation 27.3 Pediatric CNS Disorders: Febrile Seizures, Epilepsy Syndromes, Status Epilepticus, Meningitis and Encephalitis in Children, Cerebral Palsy, Hydrocephalus & Neural Tube Defects, Headache and Migraine, and Brain Tumors 27.4 Pediatric GI Disorders & Poisoning: Vomiting (Pyloric Stenosis, Atresias, Malrotation, Intussusception, GERD), Diarrhea and IMCI Rehydration Plans, Abdominal Pain, Constipation & Hirschsprung, Jaundice, Biliary Atresia & Choledochal Cyst, Hepatitis, Food Allergy, and Kerosene, Aspirin and INH Poisoning

28 Chapter 28: Pediatrics III: Genitourinary, Endocrine, Hematologic & Oncologic Disorders

28.1 Pediatric Genitourinary Disorders & Child Abuse: UTI and Vesicoureteral Reflux, Post-Streptococcal GN and Other Nephritides, Nephrotic Syndrome, AKI and HUS, CKD, Congenital Urogenital Anomalies, and Recognizing and Reporting Child Abuse 28.2 Pediatric Endocrine & Metabolic Disorders: Short Stature and Growth Hormone, Gigantism, Diabetes Insipidus, Congenital Hypothyroidism, Graves Disease & Goiter, Type 1 Diabetes and DKA, Congenital Adrenal Hyperplasia, Cushing Syndrome, Pheochromocytoma and Adrenal Crisis 28.3 Pediatric Hematology, Allergy & Immunology: Normal Hemogram and Immunoglobulins by Age, Anemias (Iron Deficiency, Thalassemia, G6PD, Spherocytosis, Aplastic), Bleeding Disorders (ITP, Hemophilia, vWD, DIC, Vitamin K), IgA Vasculitis, Rashes and Drug Reactions, Asthma, Allergic Rhinitis and Primary Immunodeficiencies 28.4 Pediatric Oncology & Genetics: Leukemias and Lymphomas, Retinoblastoma, Wilms Tumor, Neuroblastoma, Ewing Sarcoma and Osteosarcoma; Sex Chromosome and Autosomal Disorders, Inborn Errors of Metabolism and the Dysmorphic ("Odd-Looking") Child

29 Chapter 29: Preventive Medicine I: The Physician as Health Care Provider

29.1 The Physician as Health Care Provider I: Natural History of Disease, Disease Causation, Levels of Prevention and Primary Care Across the Clinical Rotations 29.2 The Physician as Health Care Provider II: The Filipino Family and Family Assessment Tools, Health Education and Promotion, Behavior Change Models and Geriatric Medicine 29.3 The Physician as Health Care Provider III: The Primary Health Care Concept (Alma-Ata, Astana, Philippine PHC) and Mental Health in Primary Care under RA 11036

30 Chapter 30: Preventive Medicine II: Philippine Health Care System & Community Medicine

30.1 The Philippine Health Care System: DOH Structure, Levels of Care and Referral, Devolution under RA 7160, the Universal Health Care Act (RA 11223), PhilHealth and YAKAP, and Leading Causes of Morbidity and Mortality 30.2 Epidemiology, Surveillance & Outbreaks: Measures of Disease Occurrence and Association, Rates, Endemic and Epidemic Levels, PIDSR and RA 11332 Notifiable Diseases, the Ten Steps of Outbreak Investigation and Epidemic Curves 30.3 DOH Programs & Environmental Sanitation: TB, Dengue, Rabies, Leprosy, Helminth and Other Disease Programs; the Sanitation Code (PD 856), Water Supply and Potability, Excreta and Solid Waste, Food Sanitation and Health Care Waste 30.4 Community Medicine: Principles of Public Health Administration and Program Planning, Vital Health Indices (Infant and Maternal Mortality), the Ecologic Concept of Health, Lifestyle and Non-Communicable Diseases, Health-Seeking Behavior and Traditional Medicine

31 Chapter 31: Preventive Medicine III: Manager, Researcher & Social Mobilizer

31.1 The Physician as Administrative Manager: Communication and Interpersonal Skills, Teamwork, Adult Learning, Occupational Health (RA 11058), Bioethics, Palliative Care, School Health, Organ Transplantation and Birth and Death Certificates 31.2 The Physician as Researcher I: The Research Process and Proposal, Research Ethics, Study Designs and Meta-Analysis, Demography and Vital Statistics, Evidence-Based Medicine and Quality Assurance 31.3 The Physician as Researcher II: Biostatistics (Data Types, Distributions, Central Tendency and Dispersion, Confidence Intervals, Hypothesis Testing and Test Selection) and Screening Tests (Validity, Predictive Values, Likelihood Ratios, Biases and Program Criteria) 31.4 The Physician as Social Mobilizer and Leader: Philippine Health Laws, Decrees and Executive Orders, Principles of Social Mobilization and Community Organizing, and Disaster Risk Reduction and Management in Health

32 Chapter 32: Pharmacology I: Principles, Cardiovascular & Nervous System Therapeutics

32.1 Pharmacology Foundations: The Pharmacology TOS, Pharmacokinetics, Drug Metabolism and Interactions, Pharmacodynamics, Adverse Drug Reactions and Monitoring, Autonomic Pharmacology, and Philippine Prescribing Rules 32.2 Cardiovascular Pharmacology I: Cardiac Arrest and ACLS Drugs, Bradycardia and Complete Heart Block, Antiarrhythmics, Anticoagulation in Atrial Fibrillation, Antianginals, ACS Therapy and Fibrinolysis, Pericarditis and Endocarditis Regimens 32.3 Cardiovascular Pharmacology II: Antihypertensives and Diuretics, Hypertensive Emergencies, Vasopressors and Inotropes in Shock, Heart Failure GDMT and Digoxin, and Lipid-Lowering Therapy 32.4 Nervous System Pharmacology I: Antiseizure Drugs and Status Epilepticus, Headache and Migraine, Vertigo, Stroke Thrombolysis and Secondary Prevention, Encephalopathy, Dementia, ADHD, Parkinson Disease and Movement Disorders, Raised Intracranial Pressure and CNS Infections

33 Chapter 33: Pharmacology II: Psychiatric, Respiratory & Genitourinary Therapeutics

33.1 Nervous System Pharmacology II: Antidepressants and Their Toxicity, Serotonin Syndrome, Anxiolytics and Hypnotics, Antipsychotics, EPS and NMS, Lithium and Mood Stabilizers, Sleep Disorders, Agitation and Alcohol Withdrawal 33.2 Respiratory Pharmacology: Cough and Colds, Allergic Rhinitis, Asthma (Controllers, Relievers, Exacerbations), COPD, Anti-TB Drugs, Antibiotics for Pneumonia and Bronchitis, and Lung Cancer Therapy 33.3 Genitourinary Pharmacology I: Antimicrobial Classes and Toxicities, and Drug Treatment of UTI, Pyelonephritis, Gonorrhea, Chlamydia, Syphilis, Genital Herpes, Genital Warts, PID, Vaginitis, Prostatitis and Orchitis 33.4 Genitourinary Pharmacology II: Kidney Stones, Nephrotic and Nephritic Disease, Drug Dosing in Kidney Disease and Hyperkalemia, Benign Prostatic Hyperplasia, Erectile Dysfunction, Renal Cell Carcinoma and Prostate Cancer Therapy

34 Chapter 34: Pharmacology III: Digestive, Endocrine, Skin & Musculoskeletal Therapeutics

34.1 Digestive Pharmacology: Portal Hypertension and Variceal Bleeding, Acid-Peptic Disease, H. pylori and GERD, Antiemetics, Laxatives and Antidiarrheals, Biliary and Pancreatic Disease, GI Infections and Parasites, Viral Hepatitis, C. difficile, Candidiasis and GI Cancer Chemotherapy 34.2 Endocrine Pharmacology I: Diabetes Mellitus Drugs (Metformin, Sulfonylureas, SGLT2 Inhibitors, GLP-1 Agonists, DPP-4 Inhibitors, Thiazolidinediones, Insulins), Choosing Therapy by Comorbidity, DKA and HHS, and Hypoglycemia 34.3 Endocrine Pharmacology II: Pituitary Disorders (GH Deficiency, Acromegaly, Prolactinoma, Diabetes Insipidus, Panhypopituitarism), Thyroid Drugs and Thyroid Storm, Calcium and Parathyroid Disorders, Adrenal Disorders and Corticosteroids 34.4 Cutaneous and Musculoskeletal Pharmacology: Cellulitis and Abscess, Drug-Induced Skin Reactions (SJS/TEN), Pain Management (Paracetamol, NSAIDs, Opioids), Osteoporosis, Rheumatoid Arthritis and Osteoarthritis, Septic and TB Arthritis, Gout, SLE and Psoriasis

35 Chapter 35: Surgery I: Basic Surgical Principles

35.1 Basic Surgical Principles I: The Surgery TOS, Fluids and Electrolytes, Acid-Base Balance, the Metabolic Response to Injury, Surgical Nutrition and Blood Transfusion 35.2 Basic Surgical Principles II: Shock and Surgical Critical Care, Hemorrhagic Shock and Massive Transfusion, ATLS Primary and Secondary Survey, Chest and Abdominal Trauma, Head and Spine Injury, Pelvic Fractures and Burns 35.3 Basic Surgical Principles III: Preoperative Assessment, Wound Healing, Surgical Infection and Asepsis, Postoperative Fever, Surgical Oncology, Immunology and Transplantation, Anesthesia and Patient Safety

36 Chapter 36: Surgery II: Abdomen, Breast & Hernia

36.1 Abdomen I: Esophagus (Hiatal Hernia, GERD, Achalasia, Caustic Injury, Barrett, Boerhaave, Mallory-Weiss, Cancer), Stomach and Duodenum (Peptic Ulcer Complications, Upper GI Bleeding, Gastric Cancer, GIST), Small Bowel (Obstruction, Ileus, Tumors, Typhoid and TB), Retroperitoneum and Abdominal Wall 36.2 Abdomen II: Gallstones, Cholecystitis, Choledocholithiasis and Cholangitis, Obstructive Jaundice, Liver (Cirrhosis, Portal Hypertension, Abscesses, Tumors and Hepatocellular Carcinoma), Pancreas (Acute and Chronic Pancreatitis, Pancreatic Cancer) and Spleen (Splenectomy, OPSI) 36.3 Abdomen III: Acute Appendicitis, Colonic Obstruction and Volvulus, Lower GI Bleeding, Diverticular Disease, Colorectal Polyps and Cancer, Hemorrhoids, Anal Fissure, Perianal Abscess and Fistula 36.4 Breast, Hernia and Skin and Soft Tissue: Benign Breast Masses, Breast Cancer Evaluation and Treatment, Groin and Abdominal Wall Hernias, Benign Skin and Soft-Tissue Tumors, Skin Cancers and Soft-Tissue Sarcoma

37 Chapter 37: Surgery III: Surgical Specialties

37.1 Head and Neck, Thyroid, Parathyroid, Endocrine and Bariatric Surgery and Otorhinolaryngology: Neck Masses and Head and Neck Cancer, Salivary Glands, Thyroid Nodules and Cancer, Goiter and Hyperthyroidism Surgery, Hyperparathyroidism, Adrenal Surgery, Bariatric Surgery, Nasal Polyps, Epistaxis, Vertigo, Hearing Loss and ENT Infections 37.2 Specialty I: Neurosurgery (Raised Intracranial Pressure and Herniation, Head Injury and Hematomas, Spontaneous Intracranial Hemorrhage, CNS and Peripheral Nerve Tumors, Spinal Cord Compression, Neurosurgical Infections) and Ophthalmology (Glaucoma, Cataract, Ophthalmic Emergencies) 37.3 Specialty II: Thoracic and Cardiovascular Surgery (Pleural Effusion and Empyema, Lung Cancer, Mediastinal Masses, Surgical Heart Disease, Aortic Aneurysm and Dissection, Peripheral Arterial and Venous Disease), Urology (Stones, Infections, Torsion, BPH, Urologic Tumors) and Gynecologic Surgery 37.4 Specialty III: Plastic and Reconstructive Surgery (Skin Grafts and Flaps, Cleft Lip and Palate, Facial Fractures, Hand Injuries), Orthopedics (Fractures, Dislocations, Bone and Joint Infections, Bone Tumors) and Pediatric Surgery (Hernias, CDH, Esophageal Atresia, Obstruction, Hirschsprung Disease, Neonatal Jaundice, Tumors)

38 Chapter 38: Medicine I: Cardiovascular, Digestive & Endocrine Medicine

38.1 Cardiovascular Medicine I: Hypertension and Secondary Causes, Dyslipidemia, Stable Angina and Acute Coronary Syndromes, Post-MI Complications, Heart Failure and Shock Syndromes 38.2 Cardiovascular Medicine II: Tachyarrhythmias and Bradyarrhythmias, Atrial Fibrillation, Sudden Cardiac Death and Brugada Syndrome, Cardiac Arrest, Valvular and Rheumatic Heart Disease, Infective Endocarditis, Myocarditis and Pericardial Disease 38.3 Gastroenterology and Hepatology: GERD and Peptic Ulcer Disease, Upper and Lower GI Bleeding, Diarrhea and GI Infections, Acute Pancreatitis and Biliary Disease, Viral Hepatitis, Cirrhosis and Portal Hypertension, Liver and GI Cancers 38.4 Endocrinology: Diabetes Mellitus Diagnosis, Treatment and Complications, DKA and HHS, Thyroid Disease, Pituitary Disorders, Adrenal Disorders (Cushing, Aldosteronism, Addison, Pheochromocytoma), Calcium and Parathyroid Disorders, Obesity and Metabolic Syndrome

39 Chapter 39: Medicine II: Hematology, Systemic Infections, Renal & Respiratory Medicine

39.1 Hematology, Immunology and Systemic Infections: Anemias (Iron Deficiency, Thalassemia, G6PD Deficiency, Megaloblastic, Hemolytic), Acute and Chronic Leukemias and Their Emergencies, Allergic Disorders, Dengue in Adults, COVID-19, Malaria and HIV/AIDS Opportunistic Infections 39.2 Nephrology: Acute Kidney Injury, Chronic Kidney Disease and Dialysis, Sodium and Potassium Disorders, Acid-Base Analysis, Urinary Tract Infections, Glomerular Diseases (Nephritic and Nephrotic), Kidney Stones, Renal Tumors and Sexually Transmitted Infections 39.3 Pulmonology and Critical Care: Acute Respiratory Failure and Oxygen Therapy, Bronchial Asthma, COPD, Community- and Hospital-Acquired Pneumonia, Pulmonary Tuberculosis and TB Infection, Pulmonary Embolism, Lung Cancer and ARDS

40 Chapter 40: Medicine III: Rheumatology, Dermatology, Neurology, Rehabilitation & Psychiatry

40.1 Rheumatology and Dermatology: Approach to Arthritis, Osteoarthritis, Rheumatoid Arthritis, Gout, Spondyloarthritis, SLE and Other Connective Tissue Diseases, Vasculitis and Myalgias, Bone Tumors, Common Skin Lesions, Skin Infections and Infestations, Eczema, Psoriasis, Severe Drug Eruptions and Skin Signs of Systemic Disease 40.2 Neurology and Rehabilitation Medicine: Stroke and TIA (Localization, Thrombolysis, Thrombectomy, Secondary Prevention), Intracranial Hemorrhage, Seizures and Status Epilepticus, Meningitis and Encephalitis, Tetanus and Rabies, Parkinsonism, Neuromuscular and Degenerative Diseases, Dementia, CNS Tumors, Post-Stroke Rehabilitation and Musculoskeletal Disorders 40.3 Psychiatry: Mental Status Examination, Depressive Disorders, Bipolar Disorder, Schizophrenia and Other Psychoses, Anxiety Disorders, OCD and Trauma-Related Disorders, Substance Use, and Acute Psychiatric Emergencies (Suicide Risk, Agitation, Withdrawal, Wernicke Encephalopathy)

9.1 Cell Injury, Adaptation, Necrosis, Apoptosis, Accumulations & Calcification

Key Takeaways Explain This Topic AI

Cell swelling from Na+/K+ ATPase failure is the earliest sign of reversible injury; mitochondrial failure and loss of membrane integrity with calcium influx mark the point of no return.

Coagulative necrosis is typical of ischemia in solid organs except the brain (liquefactive); caseous necrosis marks tuberculosis; fat necrosis marks pancreatitis; fibrinoid necrosis marks immune vasculitis and malignant hypertension.

Apoptosis shrinks single cells without inflammation through the mitochondrial (cytochrome c, caspase-9) or death-receptor (Fas, caspase-8) pathway, ending in caspase-3 and internucleosomal DNA ladders.

Dystrophic calcification occurs in dead or damaged tissue with normal serum calcium; metastatic calcification occurs in normal tissue when serum calcium or phosphate is high.

Amyloid is extracellular beta-pleated protein that stains with Congo red and shows apple-green birefringence; AL comes from light chains and AA from serum amyloid A in chronic inflammation.

Last updated: October 2026

Why this area matters

The 2025 Pathology TOS lists "cell injuries; apoptosis" first in the basic pathology area. The concepts here explain the troponin rise in myocardial infarction, the caseous lung lesion in tuberculosis, the fat necrosis of pancreatitis and the metaplasia that precedes cancer. Expect vignettes with a gross or microscopic description that ask you to name the process and its mechanism.

Causes of cell injury

The main causes are:

  • oxygen deprivation (hypoxia, ischemia);
  • physical agents (trauma, heat, radiation);
  • chemicals and drugs ;
  • infectious agents ;
  • immunologic reactions ;
  • genetic defects ;

nutritional imbalances .

The response depends on the type, duration and severity of the injury, and on the cell's type, state and adaptability. Skeletal muscle tolerates 2 to 3 hours of ischemia; cardiac muscle only 20 to 30 minutes; neurons only a few minutes.

Free radicals and reperfusion injury. Reactive oxygen species come from mitochondrial respiration, phagocyte NADPH oxidase, the Fenton reaction with iron, radiation, and drug metabolism (for example, acetaminophen's toxic NAPQI). They damage cells by lipid peroxidation of membranes, protein oxidation and DNA breaks. Cells defend themselves with superoxide dismutase, catalase, glutathione peroxidase and antioxidants such as vitamins E and C.

Restoring blood flow to ischemic tissue can paradoxically increase injury ( reperfusion injury ). The causes are a burst of free radicals, calcium overload, and influx of inflammatory cells and complement. In the heart this appears as contraction band necrosis after thrombolysis or angioplasty.

Cellular Injury: Reversible vs. Irreversible Transitions

All cellular functions depend on five critical intracellular targets: cell membrane integrity, mitochondrial ATP generation, protein synthesis machinery, the cellular cytoskeleton, and genetic apparatus integrity.

Reversible Cellular Injury

When cells face acute hypoxic, ischemic, or toxic stress, the primary biochemical lesion is the depletion of cellular ATP due to compromised mitochondrial oxidative phosphorylation:

Failure of the Sodium-Potassium ATPase Pump: Decreased ATP disrupts the electrogenic N a + / K + Na^+/K^+ N a + / K + ATPase pump on the plasma membrane. Sodium accumulates intracellularly, creating an osmotic gradient that drives water into the cytoplasm. This results in cellular swelling (hydropic change or vacuolar degeneration) , the earliest morphological hallmark of reversible cell injury.

Switch to Anaerobic Glycolysis: In an attempt to maintain energy levels, the cell accelerates anaerobic glycolysis. Intracellular glycogen stores are rapidly depleted, while lactic acid and inorganic phosphates accumulate. The resultant intracellular acidosis (decreased pH) leads to the clumping of nuclear chromatin and detachment of ribosomes from the rough endoplasmic reticulum (RER).

Detachment of Ribosomes: Dissociation of polysomes from the RER impairs protein synthesis. In cells engaged in heavy lipid metabolism (such as hepatocytes and myocardial cells), impaired synthesis of lipid-transporting apolipoproteins leads to intracellular lipid accumulation, termed fatty change (steatosis) .

Membrane Blebbing and Microvilli Effacement: Cytoskeletal disorganization leads to the formation of surface blebs and the loss of specialized cell projections.

At this stage, if normal oxygen delivery and blood flow are restored, these functional and structural derangements are entirely reversible.

Irreversible Injury and Cell Death

If the injurious stimulus persists, the cell crosses the biochemical "point of no return." Two definitive hallmarks establish irreversible cellular injury:

Permanent Mitochondrial Dysfunction: Inability to reverse mitochondrial ATP depletion, driven by the opening of the high-conductance mitochondrial permeability transition pore (MPTP) in the inner mitochondrial membrane. Opening of this pore collapses the mitochondrial membrane potential, halting ATP production and releasing pro-apoptotic molecules (such as cytochrome c) into the cytosol.

Profound Plasma Membrane Damage: Massive influx of extracellular calcium ( C a 2 + Ca^{2+} C a 2 + ) into the cytosol activates destructive endogenous enzymes:

Phospholipases: Degrade membrane phospholipids, producing progressive membrane disruption.

Proteases: Cleave cytoskeletal proteins, disrupting the submembrane scaffold.

Endonucleases: Cause progressive chromatin destruction.

ATPases: Accelerate terminal ATP depletion.

Plasma membrane rupture releases intracellular macromolecules and diagnostic enzymes into the extracellular space and bloodstream, providing clinical biomarkers of tissue necrosis (e.g., cardiac troponins I and T, CK-MB, AST, ALT, and LDH).

Nuclear Alterations in Necrosis

Microscopically, necrotic cells exhibit three progressive nuclear changes:

Pyknosis: Nuclear shrinkage and condensation with marked chromatin hyperchromasia.

Karyorrhexis: Destructive fragmentation of the pyknotic nucleus into pyknotic chromatin crumbs.

Karyolysis: Enzymatic dissolution and fading of the basophilic chromatin by lysosomal deoxyribonucleases, leaving anuclear "ghost" cells.

Cellular Adaptations to Environmental Stress

When subjected to persistent physiological or pathological stress, cells undergo adaptive responses to achieve a new steady state, preserving cell viability.

Adaptation Definition & Mechanism Key Physiologic Example Key Pathologic Example

Hypertrophy Increase in cell size without increase in cell number; driven by mechanical stretch and growth factors inducing structural protein synthesis. Skeletal muscle enlargement during resistance weight training. Left ventricular hypertrophy (LVH) secondary to systemic hypertension or aortic stenosis.

Hyperplasia Increase in cell number via stem cell proliferation; occurs only in tissues containing labile or stable cells capable of division. Compensatory liver regeneration post-hepatectomy; glandular breast proliferation during puberty and pregnancy. Benign Prostatic Hyperplasia (BPH) driven by dihydrotestosterone; Endometrial hyperplasia driven by unopposed estrogen.

Atrophy Reduction in cell size and organ mass via ubiquitin-proteasome degradation of cytoskeleton and autophagic vacuoles. Postmenopausal involution of the endometrium and breast tissue; embryologic notochord regression. Disuse atrophy of immobilized skeletal limbs; denervation atrophy in amyotrophic lateral sclerosis; ischemic renal atrophy.

Metaplasia Reversible reprogramming of stem cells to replace one differentiated adult cell type with another better suited to withstand chronic stress. Endocervical squamous metaplasia during normal hormonal shifts. Barrett esophagus (squamous to non-ciliated mucin-secreting columnar); Respiratory squamous metaplasia in chronic cigarette smokers.

Dysplasia Disordered growth and maturation characterized by cellular pleomorphism, nuclear hyperchromasia, high N:C ratio, and loss of tissue architectural orientation. None (always pathological). Cervical intraepithelial neoplasia (CIN) associated with high-risk HPV 16/18; dysplasia arising within Barrett mucosa.

The Six Morphologic Patterns of Tissue Necrosis

Necrosis represents the morphological expression of uncontrolled cell death following lethal injury, characterized by enzymatic degradation, protein denaturation, and a prominent host inflammatory response.

Pattern of Necrosis Pathophysiologic Mechanism Characteristic Histology High-Yield Board Prototype

Coagulative Necrosis Severe ischemia and hypoxia causing denaturation of both structural and enzymatic proteins; cellular autolysis is blocked. Preservation of basic tissue architecture for days; "ghost" outlines of cells with eosinophilic cytoplasm and absent nuclei. Myocardial infarction, renal infarction, splenic infarction (all solid organs except the brain).

Liquefactive Necrosis Rapid enzymatic dissolution and digestion of dead tissue by hydrolytic lysosomal enzymes; proteolysis exceeds protein denaturation. Complete transformation of tissue into a viscous, liquid mass; accumulation of necrotic debris, cellular ghosts, and neutrophils forming pus. Ischemic stroke / cerebral infarction (microglial hydrolytic enzymes); acute pyogenic bacterial and fungal abscesses.

Caseous Necrosis Chronic cell-mediated hypersensitivity reaction (Type IV) with incomplete digestion by activated macrophages. Friable, cheesy gross appearance; amorphous, granular, structureless eosinophilic debris rimmed by granulomatous inflammation. Mycobacterium tuberculosis pulmonary and nodal infection; systemic fungal infections (Histoplasmosis, Coccidioidomycosis).

Fat Necrosis Action of activated lipases splitting neutral triglycerides into free fatty acids, which complex with calcium to form insoluble soaps. Shadowy outlines of necrotic adipocytes with basophilic calcium precipitates (saponification); gross chalky-white deposits. Acute pancreatitis (enzymatic fat necrosis of peripancreatic fat); traumatic fat necrosis of the female breast.

Fibrinoid Necrosis Deposition of antigen-antibody immune complexes in blood vessel walls combined with extravasated plasma fibrin. Brightly eosinophilic, smudgy, homogeneous pink ring-like deposition within the tunica media of arterial walls. Polyarteritis nodosa (PAN), malignant hypertension, preeclampsia (placental spiral arterioles), Arthus reaction.

Gangrenous Necrosis Clinical descriptive term for ischemic coagulative necrosis of a limb, often complicated by bacterial infection. Dry gangrene : coagulative necrosis dominating; Wet gangrene : superimposed bacterial infection with liquefactive component. Peripheral artery disease / diabetic foot necrosis; bowel strangulation; Clostridium perfringens gas gangrene.

Apoptosis: Mechanisms, Pathways & Execution

Unlike necrosis, apoptosis is a tightly regulated, energy-dependent pathway of programmed cell death in which cells activate intrinsic suicide enzymes that degrade their own nuclear DNA and cytoplasmic proteins. Crucially, apoptosis maintains plasma membrane integrity, avoids cellular contents leakage, and elicits no host inflammatory response .

Molecular Pathways of Apoptosis

The Intrinsic (Mitochondrial) Pathway:

Triggered by DNA damage (UV radiation, chemotherapeutic agents), cellular stress, withdrawal of survival growth factors, or misfolded proteins.

Sensor Proteins: BH3-only proteins (BIM, BID, BAD, PUMA, NOXA) sense cellular stress and neutralize anti-apoptotic guardians.

Anti-apoptotic Guardians: BCL-2, BCL-XL, and MCL-1 normally reside on the outer mitochondrial membrane, keeping membrane channels closed.

Pro-apoptotic Effectors: BAX and BAK oligomerize in the outer mitochondrial membrane upon activation, creating pores that permit the leakage of cytochrome c into the cytosol.

In the cytosol, cytochrome c binds Apoptotic Protease Activating Factor-1 (APAF-1) , forming a wheel-shaped heptameric complex known as the apoptosome .

The apoptosome recruits and cleaves procaspase-9 into active initiator caspase-9 .

The Extrinsic (Death Receptor) Pathway:

Triggered by ligand engagement of tumor necrosis factor receptor (TNFR) superfamily members containing an intracellular "death domain."

Prototypic death receptors include FAS (CD95) and TNFR1 .

When FAS ligand (FASL, expressed on cytotoxic CD8+ T lymphocytes) binds FAS, receptor trimerization recruits the cytoplasmic adaptor protein FADD (Fas-Associated Death Domain) .

FADD recruits and cleaves procaspase-8 (or procaspase-10) into active initiator caspase-8 .

Caspase-8 can cleave the BH3-only protein BID into truncated BID (tBID) , which translocates to the mitochondria to activate BAX/BAK, linking the extrinsic pathway to the intrinsic mitochondrial pathway.

The Common Execution Phase:

Initiator caspases (caspase-9 and caspase-8) activate downstream executioner caspases: caspase-3, caspase-6, and caspase-7 .

Executioner caspases cleave cytoskeletal proteins, nuclear lamins, and the inhibitor of caspase-activated DNase (ICAD).

Freed caspase-activated DNase (CAD) translocates to the nucleus and cleaves internucleosomal DNA into fragments of uniform size (multiples of 180 to 200 base pairs), producing a characteristic DNA ladder pattern on agarose gel electrophoresis (distinct from the diffuse non-specific smear seen in necrosis).

The cell fragments into membrane-bound apoptotic bodies expressing phosphatidylserine on the outer leaflet of their plasma membranes. This "eat-me" signal triggers rapid phagocytosis by macrophages without releasing pro-inflammatory cytokines.

  • Intracellular Accumulations & Amyloidosis
  • Endogenous Pigments and Lipids

Lipofuscin ("Wear-and-Tear" Pigment): An insoluble, finely granular brownish-yellow cytoplasmic pigment composed of polymers of lipids and phospholipids complexed with protein. Derived from the free radical-induced lipid peroxidation of subcellular organelle membranes. Accumulates chronically in aging, non-dividing cells (cardiac myocytes and hepatocytes), imparting a brownish discoloration known as brown atrophy .

Hemosiderin: A golden-yellow to golden-brown granular iron-storage pigment formed by aggregates of ferritin. Visualized histochemically via the Prussian blue reaction (potassium ferrocyanide), which stains ferric iron deep blue. Localized accumulation occurs in bruises and within alveolar macrophages in chronic left heart failure ( "heart failure cells" ). Systemic overload occurs in hemochromatosis and chronic hemolytic states.

Bilirubin: Non-iron containing yellow-orange bile pigment derived from heme catabolism. Systemic accumulation produces jaundice and kernicterus in neonates.

Amyloidosis

Amyloidosis represents a group of disorders characterized by extracellular tissue deposition of misfolded, fibrillar, non-branching proteins arranged in a cross-beta-pleated sheet conformation .

Diagnostic Staining: Binds Congo red dye, producing a salmon-pink appearance under standard light microscopy. Under polarized light , amyloid exhibits pathognomonic apple-green birefringence .

AL Amyloid (Primary): Derived from monoclonal immunoglobulin light chains (predominantly lambda) secreted by dysplastic plasma cells in multiple myeloma and plasma cell dyscrasias.

AA Amyloid (Secondary): Composed of Serum Amyloid A (SAA) protein, an acute-phase reactant synthesized by the liver in response to prolonged chronic inflammation (e.g., rheumatoid arthritis, ankylosing spondylitis, Crohn disease, osteomyelitis, tuberculosis).

ATTR (Transthyretin): Derived from normal or mutated transthyretin; wild-type ATTR deposits in the myocardium of elderly patients ( senile systemic amyloidosis ), while mutant ATTR causes familial amyloid polyneuropathies and familial cardiomyopathy.

β 2 \beta_2 β 2 ​ -Microglobulin: Deposits in the synovium, joints, and carpal tunnel ligaments of patients undergoing long-term hemodialysis .

Pathologic calcification

Type Serum calcium Where it occurs Examples

Dystrophic Normal Dead or degenerating tissue Caseous tuberculous foci, atheromas, damaged or aging heart valves (calcific aortic stenosis), psammoma bodies in papillary thyroid carcinoma, serous ovarian tumors and meningioma

Metastatic High calcium or phosphate Normal tissue, especially interstitial tissue of the lungs, kidneys, gastric mucosa and blood vessels Hyperparathyroidism, vitamin D excess, bone destruction by myeloma or metastases, chronic kidney disease (secondary hyperparathyroidism and high phosphate)

Autophagy and cellular aging

Autophagy is the cell digesting its own components inside autophagic vacuoles. It helps cells survive starvation and atrophy. Cellular aging results from:

  • accumulated DNA damage;
  • telomere shortening , which leads to replicative senescence;
  • defective protein homeostasis;
  • persistent low-grade inflammation;

altered nutrient-sensing pathways.

Lipofuscin accumulation (brown atrophy) is the visible marker of long-lived cells, such as aging cardiac myocytes and hepatocytes.